Skip to content
Tenfell
Awarded contract
Published 16 Jul 2020

Purchase of Fibroscan standalone liver elastography machine

Chelsea and Westminster Hospital NHS Foundation Trust · London

Key facts

Contract value
£100,000
Awarded
29 Jun 2020
Contract starts
30 Jun 2020
Contract ends
30 Jun 2025
Procedure
Other -
Buyer type
Health

Awarded to

SupplierValue
ECHOSENS UK LIMITED£100,000

Description

The Trust required to purchase new standalone liver elastography machine.

The 'Fibroscan' is now the gold standard method to assess the degree of liver fibrosis in patients without the need for a biopsy and is used in clinical practice guidelines (including NICE) for many disorders such as Hepatitis B, Hepatitis C and Non-alcoholic fatty liver disease (NAFLD). In recent years, the number of patients being seen in the liver clinic with NAFLD has increased dramatically. This is most commonly related to being overweight. Patients with NAFLD are not only at risk of developing liver fibrosis but also are at risk of heart attacks, strokes and diabetes. The new Fibroscan machines are able to measure the amount of fat within the liver with the CAP score (controlled attenuation parameter) to diagnose this without the need for biopsy. The standard 'M-probe' that the Fibroscan uses is often unable to take an accurate reading in patients who are very overweight. In these cases, the new 'XL-probe' is required to take the Fibroscan measurements.

Categories (CPV)

Similar open tenders

About Chelsea and Westminster Hospital NHS Foundation Trust

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.